This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cancer treatment: the combination of vaccination with other therapies
Cancer Immunology, Immunotherapy Open Access 20 February 2008
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mocellin S, Semenzato G, Mandruzzato S, Riccardo RC . Part II: vaccines for haematological malignant disorders. Lancet Oncol 2004; 5: 727–737.
Shangary S, Johnson DE . Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family. Leukemia 2003; 17: 1470–1481.
Andersen MH, Becker JC, thor Straten P . The anti-apoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients. Leukemia 2005; 19: 484–485.
Andersen MH, Tan L, Sondergaard I, Zeuthen J, Elliott T, Haurum JS . Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens 2000; 55: 519–531.
Campoli M, Chang CC, Ferrone S . HLA class I antigen loss, tumor immune escape and immune selection. Vaccine 2002; 19 (Suppl 4): A40–A45.
Acknowledgements
We thank Merete Jonassen for excellent technical assistance. We thank Professor A Svejgaard and Ms Bodil K Jakobsen, Department of Clinical Immunology, University Hospital, Copenhagen, for HLA-typing of patient blood samples. Supported by grants from the Danish Medical Research Council, The Novo Nordisk Foundation, The Danish Cancer Society, The John and Birthe Meyer Foundation, Danish Cancer Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andersen, M., Kvistborg, P., Becker, J. et al. Identification of an HLA-A1 restricted CTL epitope from Mcl-1. Leukemia 19, 1084–1085 (2005). https://doi.org/10.1038/sj.leu.2403743
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403743
This article is cited by
-
Functional characterization of Foxp3-specific spontaneous immune responses
Leukemia (2013)
-
Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas
Journal of Cancer Research and Clinical Oncology (2009)
-
Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope
Leukemia (2008)
-
Cancer treatment: the combination of vaccination with other therapies
Cancer Immunology, Immunotherapy (2008)
-
Functional capacity of Mcl-1-specific cytotoxic T-cells
Leukemia (2006)